COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Kidney Blood Press Res. 2020;45(3):357-362. doi: 10.1159/000508460. Epub 2020 May 25.

Authors

Alessandra F Perna¹, Giovanna Capolongo², Francesco Trepiccione², Mariadelina Simeoni², Miriam Zacchia², Diego Ingrosso³

Affiliations

¹ Department of Medical Translational Sciences, University of Campania Luigi Vanvitelli, Naples, Italy, alessandra.perna@unicampania.it.
² Department of Medical Translational Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
³ Department of Precision Medicine,<bold></bold>University of Campania Luigi Vanvitelli, Naples, Italy.

No abstract available

Keywords: COVID-19; Hemodialysis; Low-molecular-weight heparin.

Publication types

Editorial

MeSH terms

Anticoagulants / therapeutic use*
Betacoronavirus*
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / prevention & control*
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Pandemics / prevention & control*
Pneumonia, Viral / blood
Pneumonia, Viral / prevention & control*
Renal Dialysis / methods*
Renal Dialysis / trends
SARS-CoV-2

Substances

Anticoagulants
Heparin, Low-Molecular-Weight